NCT00003460 - Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 1996

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Childhood CNS Primitive Neuroectodermal Tumor

Interventions

DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Children with a primitive neuroectodermal tumor that has not responded to standard therapy will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston